Enovis FCF/Dettes

Que fait Enovis ? Enovis Corp, listed on the stock market with ticker ENOV and ISIN US1940145022, is a health care company headquartered in Wilmington, United States. The company has 7,802 employees and went public on May 8, 2008. Enovis operates within the health care sector, focusing on medical technology and the development of clinically differentiated solutions. The company manufactures and distributes medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. It functions through two operational segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment offers products including rigid bracing, orthopedic soft goods, vascular systems, compression garments, and hot and cold therapy solutions, alongside recovery sciences products such as bone growth stimulators and electrical stimulators for clinical rehabilitation and sports medicine. The Reconstructive segment specializes in knee, hip, shoulder, elbow, foot, ankle, and finger implant products, as well as surgical productivity solutions. Additionally, Enovis provides Novastep, a minimally invasive surgery solution for foot and ankle procedures. The company's website is www.enovis.com. Enovis Corp is engaged in the production and distribution of medical devices aimed at improving patient outcomes through innovative technology and solutions in the health care industry. Enovis est l'une des entreprises les plus populaires sur Eulerpool.